| ADT | Accepted Dental Therapeutics; adenosine triphosphate; admission, discharge, transfer; agar-gel diffu... |
|---|---|
| ATP | adenosine triphosphate; ambient temperature and pressure; autoimmune thrombocytopenic purpura |
| ATP-2Na | adenosine triphosphate disodium |
| MgATP | magnesium adenosine triphosphate |
| CAMP | Christie-Atkins-Munch-Petersen [test]; computer-assisted menu planning; concentration of adenosine m... |
| D-erythro-dihydroneopterin triphosphate epimerase | <enzyme> Forms l-threo-dihydroneopterin triphosphate Registry number: EC 5.1.99.- Synonym: 2-amino-4-hydroxy-6-(d-erythro-1',2',3'-trihydroxy- propyl)-7,8-dihydropteridine triphosphate epimerase, dihydroneopterin triphosphate epimerase, folx gene product (26 Jun 1999) |
|---|---|
| diadenosine triphosphate hydrolase | <enzyme> Forms AMP Registry number: EC 3.1.4.- Synonym: ap3a hydrolase (26 Jun 1999) |
| dihydroneopterin triphosphate pyrophosphohydrolase | <enzyme> Human liver enzyme removes triphosphate to give 6-pyruvoyl-tetrahydrobiopterin Registry number: EC 3.6.1.- Synonym: 7,8-dihydroneopterin triphosphate phosphate eliminating enzyme, phosphate eliminating enzyme (26 Jun 1999) |
| inosine 5'-triphosphate | Inosine with triphosphoric acid esterified at its 5' position; participates in a number of enzyme-catalyzed reactions. Acronym: ITP (05 Mar 2000) |
| inosine triphosphate | <chemical> Inosine 5'-(tetrahydrogen triphosphate). An inosine nucleotide containing three phosphate groups esterified to the sugar moiety. Synonym: irppp. Chemical name: Inosine 5'-(tetrahydrogen triphosphate) (12 Dec 1998) |
| inositol triphosphate phosphomonoesterase | <enzyme> Human erythrocyte membrane enzyme converts inositol 1,4,5-trisphosphate into inositol 1,4-bisphosphate Registry number: EC 3.1.3.- Synonym: intp esterase, triphosphoinositide phosphomonoesterase, inositol triphosphate phosphatase, inositol triphosphate 5-phosphatase (26 Jun 1999) |
| thiamine triphosphate | <chemical> 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(4,6,8,8-tetrahydroxy-3,5,7-trioxa-4,6,8-triphosphaoct-1-yl)thiazolium hydroxide, inner salt, p,p',p''-trioxide. The triphosphate ester of thiamine. In leigh's disease, this compound is present in decreased amounts in the brain due to a metabolic block in its formation. Chemical name: Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(4,6,8,8-tetrahydroxy-3,5,7-trioxa-4,6,8-triphosphaoct-1-yl)-, inner salt, P,P',P''-trioxide (12 Dec 1998) |
| thymidine 5'-triphosphate | Thymidine esterified at its 5' position with triphosphoric acid; the immediate precursor of thymidylic acid in DNA. Acronym: dTTP (05 Mar 2000) |
| thymidine triphosphate | A molecule which consists of the nitrogenous base thymine linked to the sugar ribose and which has a chain of three phosphate groups attached to the ribose in a linear fashion. TTP is required for DNA and RNA synthesis since it is a direct precursor molecule. (09 Oct 1997) |
| erythro-dihydrobiopterin triphosphate synthetase | <enzyme> Converts 2-amino-6(5'-triphosphoribosyl)-amino-5-or -6-formamido-6-hydroxypyrimidine into quinonoid-d-erythrodihydroneopterin triphosphate Registry number: EC 3.5.4.- Synonym: dhbp-tp-synthetase (26 Jun 1999) |
| ethenoadenosine triphosphate | 1,n-6-ethenoadenosine triphosphate. A fluorescent analog of adenosine triphosphate. (12 Dec 1998) |
| uridine 5'-triphosphate | <biochemistry> Uridine esterified with triphosphoric acid at its 5'-position; the immediate precursor of uridylic acid residues in RNA. (05 Mar 2000) |
| uridine triphosphate | A molecule which consists of the nitrogenous base uracil linked to the sugar ribose and which has a chain of three phosphate groups attached to the ribose in a linear fashion. UTP is required during transcription since it is a direct precursor of RNA. (09 Oct 1997) |
| adenosine | <biochemistry> A ribonucleotide which consists of the nitrogenous base adenine linked to the sugar ribose. <drug> A cardiac drug used in terminating PSVT involving reentry pathways that include the AV node or Wolff-Parkinson-White syndrome. For atrial flutter, atrial fibrillation, atrial or ventricular tachycardias, adenosine may produce transient AV block that may help identify the rhythm. Pharmacologic action: Endogenous purine nucleoside that depresses AV node and sinus node activity. Brief duration of action (1-2 min). Dose: Rapid 6 mg IV bolus over 1-3 sec. May repeat at 12 mg IV bolus within 1-2 min Patients taking theophylline may require larger doses. Use a smaller dose with cardiac transplant patients. Potential complications: Common but transient - flushing, dyspnea, chest pain, bradycardia, and ventricular ectopy. Theophylline (and caffeine) blocks adenosine's effects. Dipyridamole potentiates adenosine's effects. Use other agents to avoid these drug interactions. (15 Mar 2000) |
| adenosine 3',5'-cyclic monophosphate | An activator of phosphorylase kinase and an effector of other enzymes, formed in muscle from ATP by adenylate cyclase and broken down to 5'-AMP by a phosphodiesterase; sometimes referred to as the "second messenger." A related compound (2',3') is also known. Synonym: cyclic adenylic acid, cyclic AMP, cyclic phosphate. Acronym: cAMP (05 Mar 2000) |